SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series

▤ Summary

This webinar series serves as an excellent foundation for our efforts to effectively apply AI in cancer patient care across the globe." "Our focus this year on AI applications is driven by the technologys unprecedented promise to significantly advance our understanding and treatment of cancer. We anticipate that this series will foster innovation, enhance cross-disciplinary engagement, and contribute to accelerating progress in cancer research, benefiting scientists at all career stages." The following are the organizers for this series: To read more about these free webinars and to see the list of expert speakers, please visit: http://www.sitcancer.CompIO About SITC Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word "cure" a reality for cancer patients everywhere.

▦ Linked Companies

NCI Information Systems, Inc.

$100M to $250M